HDAC inhibitors have been shown to upregulate the expression of regulatory genes involved in cell cycle arrest and apoptosis, such as p53, STAT, and MAPK/ERK, which are commonly silenced during cancer development and progression [11]. The gene discussed is HDAC9; the disease is cancer.